HEXO Corp HEXO HEXO announced Thursday it has gained approval from the New York Stock Exchange to transfer the listing of its common shares to NYSE from NYSE American LLC. The company expects to start trading on NYSE with the same ticker symbol on July 16.
Benzinga's Cannabis Capital Conference heads to Detroit on Aug. 15 -- Click here to learn more!
"We are extremely pleased to list on the NYSE and believe it reaffirms HEXO’s strong track-record for exceptional corporate governance and is further proof that we are a valuable cannabis industry partner for Fortune 500 companies," said CEO and co-founder Sebastien St-Louis.
HEXO is one of the biggest licensed cannabis companies in Canada. The company serves both adult-use and medical use Canadian markets through its different brands.
The stock traded around $5.15 per share Thursday morning.
Never miss a news story in the cannabis world. Click here to check out Benzinga Cannabis for more.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
